Lilly to Integrate Dexcom CGM into Personalized Diabetes Management System
Go back to Lilly to Integrate Dexcom CGM into Personalized Diabetes Management System| DexCom, Inc. (NASDAQ: DXCM) | Delayed: 84.75 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $84.75 | 52 Week High | $96.38 | |||
| Open | $84.75 | 52 Week Low | $47.92 | |||
| Day High | $84.75 | P/E | N/A | |||
| Day Low | $84.75 | EPS | $-0.42 | |||
| Volume | 5,570 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1185.71 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1185.71 | 52 Week High | $88.16 | |||
| Open | $1185.71 | 52 Week Low | $67.88 | |||
| Day High | $1185.71 | P/E | 274.47 | |||
| Day Low | $1185.71 | EPS | $4.32 | |||
| Volume | 13,356 | |||||

